Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
1. To determine the effect of Golimumab treatment on the number and function of Endothelial
Progenitor Cells (EPCs) in Ankylosing Spondylitis(AS) patients as a possible mechanism
for the effect of this treatment on endothelial function.
2. To ascertain the effect of Golimumab treatment on , carotid intima-media thickness,
vascular stiffness in Ankylosing Spondylitis(AS) patients as measured by pulse wave
velocity (PWV) and Augmentation index (AIx).
3. To assess the clinical efficacy of Golimumab in Chinese Ankylosing Spondylitis(AS)
patients according to ASAS response criteria at month 3, 6 and 12.
4. To perform cost-effectiveness and cost-utility analyses of the Golimumab in Ankylosing
Spondylitis(AS) patients, using clinic-base data.